Women in Pharma Doubles Turnout at Product Show

Posted by Christine Conley
On September 25, 2019

The ISPE Boston Area Chapter’s Women in Pharma (WIP) group held their second annual meeting at the Product Show at Gillette Stadium this past Wednesday, 17 September 2019. This meeting included a year in review of all of the exciting and interactive events that occurred in the first year including: a career story presented by […]

Product Show Highlights “Building Pharmaceutical Facilities for the Future”

Posted by ISPE Boston
On September 17, 2019

When building a pharmaceutical facility there are a lot of things to consider. The facility layout must satisfy the process flow, logistics and cGMP classification, as well as the safety requirements of the personnel using the facility. When considering the practicalities of the design, one of the aspects often overlooked until the final stages of […]

Chapter Board Member Caren Jenkins Talks ISPE, Yoga and Zoey, too…

Posted by ISPE Boston
On September 12, 2019

1. What do you currently do? Business Development and Marketing 2. How long have you been in the industry? Since 2012, I transitioned in from a completely different industry. I am a non-engineer in a very technically-focused industry. 3. How has your time as an ISPE member benefitted you? ISPE has opened so many doors […]

Veterans in Pharma Meet Up at the Product Show

Posted by ISPE Boston
On September 11, 2019

By Leighton Terwilliger, Casella Process Solutions At the Product Show on September 18 we will have the new Veterans in Pharma initiative kicking off. This is a great opportunity for veterans looking to get into the biopharma industry – or companies looking to hire veterans – to get together and interact, as well as a […]

Navigating Growing Pains for Biopharmas Experiencing Rapid Growth

Posted by ISPE Boston
On September 11, 2019

Biotechnology is one of the fastest growing markets both globally and domestically. Join us during the “Innovation in Facility Design” educational track at the Product Show on September 18 and hear a panel of industry experts discuss meeting the challenges – and opportunities – that go hand in hand with rapid growth. With the US […]

Leveraging ISPE for Your Professional Development

Posted by Cory Siddons
On September 11, 2019

Are you looking to improve your technical skills in a particular field? Learn about new and emerging technologies? Improve your communication, management, and leadership skills? If you answered “Yes” to any of these questions, keep reading. We may find opportunities for professional development and mentorship within our companies or peer groups, or through self-directed skill […]

Congratulations to our June 2019 Scholarship Winners!

Posted by ISPE Boston
On September 9, 2019

The Chapter is proud to award $12,500 in scholarships to the following winners of the June 2019 round of the Joel Goldenberg Memorial Scholarship Program: Bensu Altan, Northeastern University Krishna Dixit, Naugatuck Valley Community College Bunnarene Hang, Middlesex Community College Kinza Hussain, University of New England College of Osteopathic Medicine Elizabeth McCain, Northeastern University Abigail […]

Vertex Targets Type 1 Diabetes Cure with Acquisition of Semma Therapeutics

Posted by ISPE Boston
On September 4, 2019

Vertex Pharmaceuticals has announced that it has entered into an agreement to acquire Semma Therapeutics for $950 million in cash, with the acquisition expected to close in the fourth quarter of 2019. With locations in Cambridge and Providence, Semma is a privately-held biotech pioneering the use of stem cell-derived human islets as a potentially curative […]

Bristol-Myers Squibb and Celgene Clear Path for Merger

Posted by ISPE Boston
On September 4, 2019

Bristol-Myers Squibb (BMS) has announced that Celgene Corporation, in connection with its merger agreement with Bristol-Myers Squibb, has entered into an agreement with Amgen under which Amgen would acquire the global rights to Otezla® (apremilast) for $13.4 billion in cash. BMS previously announced the decision to divest Otezla in connection with the ongoing regulatory approval […]

Sneak Preview: Product Show Highlights Data Management for Individualized Therapies

Posted by ISPE Boston
On September 4, 2019

Individualized medicines, such as CAR-T cell therapies, are expensive, with no room for failure. It is often a situation where the manufacture of the medicine truly is a life or death situation. So how does a small biotech firm leverage cutting edge data systems to build in quality, reduce errors, and deliver on time? Moreover, […]

Page 78 of 118«‹76 777879 80 ›»